Glycogen storage disease type I patients with hyperlipidemia have no signs of early vascular dysfunction and premature atherosclerosis

被引:4
作者
Schmitt, Johannes [1 ]
Wurm, Michael [2 ]
Schwab, K. Otfried [1 ]
Spiekerkoetter, Ute [1 ]
Hannibal, Luciana [3 ]
Gruenert, Sarah C. [1 ]
机构
[1] Univ Freiburg, Dept Gen Pediat Adolescent Med & Neonatol, Med Ctr, Fac Med, D-79106 Freiburg, Germany
[2] Univ Childrens Hosp Regensburg, Dept Pediat, St Hedwigs Campus, D-93049 Regensburg, Germany
[3] Univ Freiburg, Dept Gen Pediat Adolescent Med & Neonatol, Lab Clin Biochem & Metab, Fac Med,Med Ctr, D-79106 Freiburg, Germany
关键词
Glycogen storage disease; G6PC; Glucose-6-phosphatase; Atherosclerosis; Vascular dysfunction; Cardiovascular disease; INTIMA-MEDIA THICKNESS; FATTY-ACID-COMPOSITION; OXIDATIVE STRESS; ENDOTHELIAL FUNCTION; RISK-FACTORS; CHILDREN; PLASMA; HYPERGLYCEMIA; ULTRASOUND; PREDICTION;
D O I
10.1016/j.numecd.2021.08.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: Glycogen storage disease type I (GSD I) is associated with hyperlipidemia, a known risk factor for premature atherosclerosis. Few studies have addressed endothelial dysfunction in patients with GSD I, and these studies yielded controversial results. Methods and results: We investigated vascular dysfunction in a cohort of 32 patients with GSD I (26 GSD Ia, 6 GSD Ib, mean age 20.7 (4.8-47.5) years) compared to 32 age-, gender-, and BMImatched healthy controls using non-invasive techniques such as quantification of carotid intima media thickness, retinal vessel analysis and 24 h-blood pressure measurements. In addition, early biomarkers of inflammatory and oxidative endothelial stress were assessed in blood. Although GSD I patients had a clearly proatherogenic lipid profile, increased oxidative stress, higher levels of high sensitivity C-reactive protein and increased lipoprotein associated phospholipase A2 activity, functional and structural parameters including carotid intima media thickness and retinal vessel diameters did not indicate premature atherosclerosis in this patient cohort. Blood pressure values and pulse wave velocity were comparable in patients and healthy controls, while central blood pressure and augmentation index were higher in GSD patients. Conclusion: Our data suggest that GSD I is not associated with early vascular dysfunction up to the age of at least 20 years. Further studies are needed to elucidate the possibly protective mechanisms that prevent early atherosclerosis is GSD I. Longer follow-up studies are required to assess the long-term risk of vascular disease with increased oxidative stress being present in GSD I patients. (c) 2021 Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University.
引用
收藏
页码:3384 / 3392
页数:9
相关论文
共 50 条
  • [21] OCULAR CHANGES OF GLYCOGEN-STORAGE-DISEASE TYPE-I
    ABE, T
    TAMAI, M
    OPHTHALMOLOGICA, 1995, 209 (02) : 92 - 95
  • [22] Glycogen Storage Disease Type I With Hypercalcemia in an Infant: A Case Report
    Elouali, Aziza
    N'joumi, Chaimae
    Bennani, Amal
    Rkain, Maria
    Babakhouya, Abdeladim
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [23] Progressive development of renal cysts in glycogen storage disease type I
    Gjorgjieva, Monika
    Raffin, Margaux
    Duchampt, Adeline
    Perry, Ariane
    Stefanutti, Anne
    Brevet, Marie
    Tortereau, Antonin
    Dubourg, Laurence
    Hubert-Buron, Aurelie
    Mabille, Mylene
    Pelissou, Coralie
    Lassalle, Louis
    Labrune, Philippe
    Mithieux, Gilles
    Rajas, Fabienne
    HUMAN MOLECULAR GENETICS, 2016, 25 (17) : 3784 - 3797
  • [24] Glycogen storage disease type I: indications for liver and/or kidney transplantation
    Philippe Labrune
    European Journal of Pediatrics, 2002, 161 (1) : S53 - S55
  • [25] Cell death and stress signaling in glycogen storage disease type I
    Kim, So Youn
    Bae, Yun Soo
    MOLECULES AND CELLS, 2009, 28 (03) : 139 - 148
  • [26] Glycogen storage disease type I: indications for liver and/or kidney transplantation
    Labrune, P
    EUROPEAN JOURNAL OF PEDIATRICS, 2002, 161 (Suppl 1) : S53 - S55
  • [27] Glycemic control and complications in glycogen storage disease type I: Results from the Swiss registry
    Kaiser, Nathalie
    Gautschi, Matthias
    Bosanska, Lenka
    Meienberg, Fabian
    Baumgartner, Matthias R.
    Spinas, Giatgen A.
    Hochuli, Michel
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (04) : 355 - 361
  • [28] Contrast-Enhanced Ultrasonography in Patients With Glycogen Storage Disease Type Ia and Adenomas
    Nguyen, Anh T.
    Bressenot, Aude
    Manole, Simona
    Galloy, Marie A.
    Bronowicki, Jean P.
    Vidailhet, Michel
    Feillet, Francois
    Claudon, Michel
    JOURNAL OF ULTRASOUND IN MEDICINE, 2009, 28 (04) : 497 - 505
  • [29] A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III
    Ucar, S. Kalkan
    Coker, M.
    Sozmen, E.
    Simsek, D. Goksen
    Darcan, S.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2009, 19 (06) : 383 - 390
  • [30] Glycogen storage disease type I a: Frequency and clinical course in Turkish children
    Saltik I.N.
    Özen H.
    Ciliv G.
    Koçak N.
    Yüce A.
    Gürakan F.
    Dinler G.
    The Indian Journal of Pediatrics, 2000, 67 (7) : 497 - 501